Skip to Main Content

After years of rumors, Sana Biotechnology is officially biotech’s newest unicorn.

The company announced Tuesday that it has raised $700 million — one of the largest initial financing rounds for a biotech startup ever. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!